🎙️ LIVE in #ESCCongress 2025 and simultaneously published in #EJPC 💊 Can lipid-lowering therapy help people aged ≥75 without CVD live longer? 📃 US cohort study (>6,400 participants) ⬇️ 26% lower all-cause mortality ⬇️ 36% lower CV mortality ➕ ~1.6 years longer survival 🔗

#CEPT inhibitors making a comeback! #ESCCongress Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients 📍pooled analysis: 2884 pts, mean age 66y, 36%💃🏻, 82% ASCVD, RCT 10 mg obicetrap 🆚 placebo: •LDL‑C ↓ by –37.8% 🆚 –4.6% •ApoB ↓ by –21.7% 🆚

JOIN our next #EAPC JournalClub on elevated Lp(a) linked to new onset AF 🤔 in collaboration with EHRAPresident 🗓️ 25th Sep 2026 | 17:00 CEST EAPCPresident Sam Tsimikas, MD Gal Tsaban Vasiliki Tsampasian Svetlana Mosteoru #Lipoprotein #Atrialfibrallation

The new issue of the European Journal of Preventative Cardiology focuses on Heart Failure. Don't miss the issue @ a glance! 🔍 academic.oup.com/eurjpc/article… European Society of Cardiology Victor Aboyans Silvia Castelletti Francesco Perone Vasiliki Tsampasian Buket Akıncı #cvprev #cardiotwitter

Am so delighted about our Official European Society of Cardiology Statement on Long COVID #covid #longcovid - we discuss evidence available, investigation pathways, treatments, #vaccines, carciac rehab & more- in EJPC Editor-in-Chief Definitely worth a read! 🙏 to coauthors academic.oup.com/eurjpc/advance… Pls RT!

See 👆 for our consensus statement on Long #COVID academic.oup.com/eurjpc/advance… Grateful for RT! Mamas A. Mamas Prof Amitava Banerjee💙 Benoy Shah MD K8 Edinson Garcia. MD Pankaj Garg Tim Kambič Gal Tsaban Svetlana Mosteoru Buket Akıncı Shelley Zieroth John P Erwin III MD MBA MACC (#BigPoppy ) Beth Frates MD

🚨 New Consensus Statement 🚨 Cardiovascular disease prevention & management in COVID-19 – published by #EAPC #EACVI #ACNAP #EAPCI & #HFA of the European Society of Cardiology. 📖 Read academic.oup.com/eurjpc/advance… EAPCPresident ACNAPPresident EAPCIPresident HFAPresident

📢 Save the Date! #EACVI2025 | 11–13 Dec 2025 | Vienna 🇦🇹 Uniting #Echocardiography, #CMR, #CardiacCT & #NuclearCardiology 🌍 Building on EuroEcho-Imaging, ICNC-CT & EuroCMR ✨ Join us! 🩷 esc365.escardio.org/EACVI-Congress Early registration ends 30/09! EACVI President Victoria Delgado

Both Haemodynamic Gain Index and peak rate-pressure product are predictors of mortality in patients with chronic HF and may be tools to signal the need for advanced HF therapy evaluation 🔍 academic.oup.com/eurjpc/article… European Society of Cardiology Victor Aboyans Silvia Castelletti Francesco Perone #cvprev

📌Baseline nitric oxide (NO) metabolite profile is unfavourable in patients with HF and lower VO2peak or higher NT-proBNP 🚫No significant influence of HIIT or MCT on NO metabolites at 3 and 12 months academic.oup.com/eurjpc/article… European Society of Cardiology Victor Aboyans Silvia Castelletti Francesco Perone

A1: No, Familial Hypercholesterolemia (FH) is not a rare condition; in fact, it is one of the most common genetic disorders, affecting about 1 in 250 people globally and up to 1.3 million people in the U.S. alone #KnowFH #FHAwarenessDay ASPC

In community-dwelling older adults without anaemia, lower plasma hepcidin levels associate with a higher risk of incident HF (particularly HFpEF) and diastolic dysfunction 🧓👵 💻academic.oup.com/eurjpc/article… European Society of Cardiology Victor Aboyans Silvia Castelletti Francesco Perone Vasiliki Tsampasian Buket Akıncı

The global cardiovascular disease (CVD) burden is expected to rise in the next few decades, driven primarily by an ageing populace worldwide. High blood pressures, dietary risks, and high cholesterol are the predominant risk factors expected to drive CVD. academic.oup.com/eurjpc/article…

✅Increasing numbers of modifiable lifestyle risk factors (modLRF) are associated with elevated concentrations of hsTnT and I ✅The predictive capability of troponins varies according to the presence of modLRF academic.oup.com/eurjpc/article… European Society of Cardiology Victor Aboyans Silvia Castelletti #cvprev

🏊 Paddling Through Palpitations – European Society of Cardiology #EAPC Test Your Knowledge ✔️ Case-based challenges that sharpen instinct ✔️ Palpitations in the context of cardiovascular risk ✔️ Active learning: think, decide, reflect ♥️ Recommended for EP, preventive & general cardiology.

📢 New study in EJPC: “One-year treatment trajectories of patients with statin intolerance: results from a multicentre registry” 🩺39% still report pain, 75% miss LDL targets, and women receive fewer treatment escalations. 👉 Read the full article: tinyurl.com/3nnuv23b

Mitral annular dysjunction-associated fibrosis on #WhyCMR 🩻 Learn how to spot scar in this condition in this excellent paper published in EHJ-IMP Editor-in-Chief 🤩 1/4 patients with MAD = basal inferolateral scar Alessia Gimelli Victoria Delgado Pablo Pérez López academic.oup.com/ehjimp/article…

🩺💻 A #telemedicine-based lipid-lowering strategy helped 82.6% of post-ACS patients reach LDL-c targets (<55 mg/dL) in just 3.2 months with improved #lipidcontrol and reduced #cardiovascular mortality. 🔗 tinyurl.com/kew86u62

💥 The “Global Leadership Initiative on Sarcopenia (GLIS)” model redefines sarcopenia not just by muscle mass or strength, but by clinical outcomes. 🏥 In 891 older HF patients, GLIS-defined sarcopenia=3.4×⬆️ 2-year mortality. 🚨 Prognosis matters! 🔗 tinyurl.com/37h25pja

Super presentation on TV and the R Heart by Denisa Muraru at BSEcho . Valuable insights on eRVEF & also which patients with moderate TR to refer to Heart Valve Centres BSE President Benoy Shah MD Vasiliki Tsampasian Anastasia Vamvakidou Melanie Ackrill #bsecho2025